Kura Oncology Inc (KURA)

9.01 +0.04 (+0.45%) USD  |  NASDAQ  |  Dec 20, 16:00
9.10 +0.09 (+1.00%) After-Hours: 20:00
More

Kura Oncology Enterprise Value: 254.83M for Dec. 20, 2024

Enterprise Value Chart

View Enterprise Value for KURA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Enterprise Value Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Enterprise Value Definition

View Enterprise Value Definition
Start Trial

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Halozyme Therapeutics Inc 6.809B
AIM ImmunoTech Inc 7.634M
Perspective Therapeutics Inc -73.53M
Protalix BioTherapeutics Inc 102.19M
Armata Pharmaceuticals Inc 160.82M

Enterprise Value Related Metrics

Net Income (Quarterly) -54.40M
Total Expenses (Quarterly) 59.88M
EPS Diluted (Quarterly) -0.63
Earnings Yield -26.19%